St. Louis School of Medicine: Immunotherapy for Alzheimer's Disease Shows Promise in Mouse Study
April 04, 2024
April 04, 2024
ST. LOUIS, Missouri, April 4 (TNSres) -- The Washington University St. Louis School of Medicine issued the following news release:
* * *
Antibody mobilizes immune cells to clear amyloid plaques, reducing behavioral abnormalities
* * *
Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation . . .
* * *
Antibody mobilizes immune cells to clear amyloid plaques, reducing behavioral abnormalities
* * *
Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation . . .